{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:05:08Z","timestamp":1778400308240,"version":"3.51.4"},"reference-count":41,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Incyte Corporation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Janus kinase (JAK)\/signal transducer and activator of transcription signaling (STAT) has been implicated in the pathophysiology of hidradenitis suppurativa (HS). This study evaluated treatment-related transcriptomic and proteomic changes in patients with moderate-to-severe HS treated with the investigational oral JAK1-selective inhibitor povorcitinib (INCB054707) in two phase 2 trials. Lesional skin punch biopsies (baseline and Week 8) were taken from active HS lesions of patients receiving povorcitinib (15 or 30 mg) once daily (QD) or a placebo. RNA-seq and gene set enrichment analyses were used to evaluate the effects of povorcitinib on differential gene expression among previously reported gene signatures from HS and wounded skin. The number of differentially expressed genes was the greatest in the 30 mg povorcitinib QD dose group, consistent with the published efficacy results. Notably, the genes impacted reflected JAK\/STAT signaling transcripts downstream of TNF-\u03b1 signaling, or those regulated by TGF-\u03b2. Proteomic analyses were conducted on blood samples obtained at baseline and Weeks 4 and 8 from patients receiving povorcitinib (15, 30, 60, or 90 mg) QD or placebo. Povorcitinib was associated with transcriptomic downregulation of multiple HS and inflammatory signaling markers as well as the reversal of gene expression previously associated with HS lesional and wounded skin. Povorcitinib also demonstrated dose-dependent modulation of several proteins implicated in HS pathophysiology, with changes observed by Week 4. The reversal of HS lesional gene signatures and rapid, dose-dependent protein regulation highlight the potential of JAK1 inhibition to modulate underlying disease pathology in HS.<\/jats:p>","DOI":"10.3390\/ijms24087185","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T02:29:15Z","timestamp":1681352955000},"page":"7185","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies"],"prefix":"10.3390","volume":"24","author":[{"given":"Huiqing","family":"Liu","sequence":"first","affiliation":[{"name":"Incyte Corporation, Wilmington, DE 19803, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9986-6047","authenticated-orcid":false,"given":"Leandro L.","family":"Santos","sequence":"additional","affiliation":[{"name":"Incyte Corporation, Wilmington, DE 19803, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan H.","family":"Smith","sequence":"additional","affiliation":[{"name":"Incyte Corporation, Wilmington, DE 19803, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamadermatol.2020.5467","article-title":"Global harmonization of morphological definitions in hidradenitis suppurativa for a proposed glossary","volume":"157","author":"Frew","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2040622319830646","DOI":"10.1177\/2040622319830646","article-title":"Topical, systemic and biologic therapies in hidradenitis suppurativa: Pathogenic insights by examining therapeutic mechanisms","volume":"10","author":"Frew","year":"2019","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jid.2020.06.019","article-title":"A systematic review of promising therapeutic targets in hidradenitis suppurativa: A critical evaluation of mechanistic and clinical relevance","volume":"141","author":"Frew","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: An update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.14214","article-title":"What causes hidradenitis suppurativa?-15 years after","volume":"29","author":"Zouboulis","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bjd.20642","article-title":"Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa","volume":"186","author":"Navrazhina","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2021.05.027","article-title":"High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression","volume":"149","author":"Navrazhina","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00011-020-01381-7","article-title":"Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis","volume":"69","author":"Rumberger","year":"2020","journal-title":"Inflamm. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Coates, M., Mariottoni, P., Corcoran, D.L., Kirshner, H.F., Jaleel, T., Brown, D.A., Brooks, S.R., Murray, J., Morasso, M.I., and MacLeod, A.S. (2019). The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216249"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"De Oliveira, A., Bloise, G., Moltrasio, C., Coelho, A., Agrelli, A., Moura, R., Tricarico, P.M., Jamain, S., Marzano, A.V., and Crovella, S. (2022). Transcriptome meta-analysis confirms the hidradenitis suppurativa pathogenic triad: Upregulated inflammation, altered epithelial organization, and dysregulated metabolic signaling. Biomolecules, 12.","DOI":"10.3390\/biom12101371"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2133.2012.10802.x","article-title":"Hidradenitis suppurativa and immune dysregulation","volume":"166","author":"Jemec","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/wound.2014.0608","article-title":"The innate immune system in acute and chronic wounds","volume":"5","author":"MacLeod","year":"2015","journal-title":"Adv. Wound Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/exd.14338","article-title":"Target molecules for future hidradenitis suppurativa treatment","volume":"30","author":"Zouboulis","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3389\/fimmu.2019.02342","article-title":"Targeting the Janus kinase family in autoimmune skin diseases","volume":"10","author":"Howell","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction","volume":"139","author":"Wolk","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3389\/fimmu.2019.02847","article-title":"Emerging topical and systemic JAK inhibitors in dermatology","volume":"10","author":"Solimani","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_18","first-page":"2450401","article-title":"The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa","volume":"2017","author":"Rodriguez","year":"2017","journal-title":"Mediators Inflamm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/bjd.20969","article-title":"Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: Results from two phase 2 studies","volume":"186","author":"Alavi","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/bjd.18309","article-title":"Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: Proposed recommendations for clinical trials and translational research studies","volume":"181","author":"Frew","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"a015222","DOI":"10.1101\/cshperspect.a015222","article-title":"Sweat gland progenitors in development, homeostasis, and wound repair","volume":"4","author":"Lu","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fgene.2018.00739","article-title":"Defining key genes regulating morphogenesis of apocrine sweat gland in sheepskin","volume":"9","author":"Li","year":"2018","journal-title":"Front. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00418-008-0435-6","article-title":"The human keratins: Biology and pathology","volume":"129","author":"Moll","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10735-020-09855-y","article-title":"K31 as a novel marker for clear secretory cells in human eccrine sweat glands","volume":"51","author":"Du","year":"2020","journal-title":"J. Mol. Histol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1073\/pnas.1117213109","article-title":"Forkhead transcription factor FoxA1 regulates sweat secretion through Bestrophin 2 anion channel and Na-K-Cl cotransporter 1","volume":"109","author":"Cui","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/13547500903075218","article-title":"Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging","volume":"14","author":"Matusiak","year":"2009","journal-title":"Biomarkers"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08820139.2016.1230867","article-title":"Interferon-gamma (IFN-\u03b3) is elevated in wound exudate from hidradenitis suppurativa","volume":"46","author":"Banerjee","year":"2017","journal-title":"Immunol. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08830185.2021.1931171","article-title":"The role of sialic acid-binding immunoglobulin-like-lectin-1 (siglec-1) in immunology and infectious disease","volume":"42","author":"Prenzler","year":"2021","journal-title":"Int. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/cr.2015.108","article-title":"Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27","volume":"25","author":"Zheng","year":"2015","journal-title":"Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R260","DOI":"10.1186\/ar4105","article-title":"Raised circulating tenascin-C in rheumatoid arthritis","volume":"14","author":"Page","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s13075-015-0862-4","article-title":"Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: A cohort study","volume":"17","author":"Uher","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yuan, W., Zhang, W., Yang, X., Zhou, L., Hanghua, Z., and Xu, K. (2018). Clinical significance and prognosis of serum tenascin-C in patients with sepsis. BMC Anesthesiol., 18.","DOI":"10.1186\/s12871-018-0634-1"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"152071","DOI":"10.1016\/j.imbio.2021.152071","article-title":"The role of dectin-1 in health and disease","volume":"226","author":"Kalia","year":"2021","journal-title":"Immunobiology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamadermatol.2021.4926","article-title":"Identification of biomarkers and critical evaluation of biomarker validation in hidradenitis suppurativa: A systematic review","volume":"158","author":"Hessam","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_36","first-page":"e139932","article-title":"Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-\u03b1 therapy","volume":"5","author":"Lowe","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjd.20097","article-title":"Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa","volume":"185","author":"Cao","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2016.08.036","article-title":"Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa","volume":"76","author":"Cornille","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: Clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"eaap8798","DOI":"10.1126\/scitranslmed.aap8798","article-title":"Transcriptional signature primes human oral mucosa for rapid wound healing","volume":"10","author":"Uchiyama","year":"2018","journal-title":"Sci. Transl. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7185\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:13Z","timestamp":1760123713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24087185"],"URL":"https:\/\/doi.org\/10.3390\/ijms24087185","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]}}}